Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Nautilus Biotechnology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Nautilus Biotechnology
Nautilus Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?